Suzanne Kafaja

Title(s)HS Associate Clinical Professor, Medicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 2023 09; 75(9):1608-1618. Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyznski P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP, RESOLVE-1 Study Group. PMID: 37098795.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    2. Autologous Stem Cell Transplantation With Intensity Modulated Total Body Irradiation Conditioning for Systemic Sclerosis. Int J Radiat Oncol Biol Phys. 2023 08 01; 116(5):1019-1024. Ladbury C, Mei M, Kafaja S, Nall J, Han C, Dandapani S, Forman S, Wong JYC. PMID: 36868524.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Factors associated with life satisfaction in systemic sclerosis: Examining the moderating roles of social support and spiritual well-being. J Scleroderma Relat Disord. 2023 Jun; 8(2):107-112. Chen YT, Murphy SL, Furst DE, Clements P, Kafaja S, Tsevat J, Malcarne V, Khanna D. PMID: 37283281; PMCID: PMC10202482.
      View in: PubMed   Mentions:
    4. Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial. Arthritis Rheumatol. 2022 08; 74(8):1399-1408. Khanna D, Caldron P, Martin RW, Kafaja S, Spiera R, Shahouri S, Shah A, Hsu V, Ervin J, Simms R, Domsic RT, Steen V, Hummers LK, Derk C, Mayes M, Chatterjee S, Varga J, Kesten S, Fraser JK, Furst DE. PMID: 35358372; PMCID: PMC9544105.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    5. Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients. J Scleroderma Relat Disord. 2021 Oct; 6(3):236-241. Suliman YA, Kafaja S, Alemam M, Shaweesh Y, Tavakoli K, Furst DE. PMID: 35387210; PMCID: PMC8922669.
      View in: PubMed   Mentions:
    6. Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts. Clin Rheumatol. 2021 Jun; 40(6):2277-2284. Suliman Y, Kafaja S, Oh SJ, Alemam M, Bagnato G, Abignano G, Singh RR, Barlow G, Liu X, Valera I, Morales W, Rezaie A, Pimentel M, Del Galdo F, Furst DE. PMID: 33231773.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial. Lancet Rheumatol. 2020 12; 2(12):e743-e753. Chung L, Spino C, McLain R, Johnson SR, Denton CP, Molitor JA, Steen VD, Lafyatis R, Simms RW, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Sandorfi N, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Allanore Y, Matucci-Cerinic M, Whitfield ML, Distler O, Singer O, Young A, Nagaraja V, Fox DA, Furst DE, Khanna D. PMID: 34966900; PMCID: PMC8713509.
      View in: PubMed   Mentions: 18  
    8. HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):552-562. Gourh P, Safran SA, Alexander T, Boyden SE, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA, Ramos PS, Silver RM, Steen VD, Varga J, Hsu V, Saketkoo LA, Schiopu E, Khanna D, Gordon JK, Kron B, Criswell LA, Gladue H, Derk CT, Bernstein EJ, Bridges SL, Shanmugam VK, Kolstad KD, Chung L, Kafaja S, Jan R, Trojanowski M, Goldberg A, Korman BD, Steinbach PJ, Chandrasekharappa SC, Mullikin JC, Adeyemo A, Rotimi C, Wigley FM, Kastner DL, Boin F, Remmers EF. PMID: 31871193; PMCID: PMC6955366.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    9. Validity and correlates of the Brief Satisfaction With Appearance Scale for patients with limited and diffuse systemic sclerosis: Analysis from the University of California, Los Angeles Scleroderma Quality of Life Study. J Scleroderma Relat Disord. 2020 Jun; 5(2):143-151. Fox RS, Mills SD, Gholizadeh S, Merz EL, Roesch SC, Clements PJ, Kafaja S, Khanna D, Furst DE, Malcarne VL. PMID: 35382027; PMCID: PMC8922615.
      View in: PubMed   Mentions: 1  
    10. Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Arthritis Rheumatol. 2020 01; 72(1):125-136. Khanna D, Spino C, Johnson S, Chung L, Whitfield ML, Denton CP, Berrocal V, Franks J, Mehta B, Molitor J, Steen VD, Lafyatis R, Simms RW, Gill A, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Schiopu E, Young A, Sandorfi N, Park J, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Wang Y, Wood T, Allanore Y, Matucci-Cerinic M, Distler O, Singer O, Bush E, Fox DA, Furst DE. PMID: 31342624; PMCID: PMC6935399.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCTClinical Trials
    11. The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA). Clin Rheumatol. 2020 Jan; 39(1):189-199. Barroso N, Woodworth TG, Furst DE, Guillemin F, Fautrel BJ, Borazan N, Kafaja S, Brook J, Elashoff DA, Ranganath VK. PMID: 31493148.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology (Oxford). 2018 09 01; 57(9):1623-1631. Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauvé M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larché M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD, SPIN Investigators. PMID: 29868924.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    13. Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans. Arthritis Rheumatol. 2018 10; 70(10):1654-1660. Gourh P, Remmers EF, Boyden SE, Alexander T, Morgan ND, Shah AA, Mayes MD, Doumatey A, Bentley AR, Shriner D, Domsic RT, Medsger TA, Steen VD, Ramos PS, Silver RM, Korman B, Varga J, Schiopu E, Khanna D, Hsu V, Gordon JK, Saketkoo LA, Gladue H, Kron B, Criswell LA, Derk CT, Bridges SL, Shanmugam VK, Kolstad KD, Chung L, Jan R, Bernstein EJ, Goldberg A, Trojanowski M, Kafaja S, Maksimowicz-McKinnon KM, Mullikin JC, Adeyemo A, Rotimi C, Boin F, Kastner DL, Wigley FM. PMID: 29732714; PMCID: PMC6160338.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. Validation of Sonography findings of synovitis and tenosynovitis of hands and wrists in patients with systemic sclerosis. J Scleroderma Relat Disord. 2018 Oct; 3(3):228-236. Scheiman-Elazary A, Ranganath VK, Ben-Artzi A, Kafaja S, Borazan NH, Woodworth T, Duan L, Elashoff D, Clements P, Furst DE. PMID: 35382015; PMCID: PMC8922605.
      View in: PubMed   Mentions: 1  
    15. pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis. JCI Insight. 2018 05 03; 3(9). Kafaja S, Valera I, Divekar AA, Saggar R, Abtin F, Furst DE, Khanna D, Singh RR. PMID: 29720568; PMCID: PMC6012518.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    16. Ultrasound characterization of cutaneous ulcers in systemic sclerosis. Clin Rheumatol. 2018 Jun; 37(6):1555-1561. Suliman YA, Kafaja S, Fitzgerald J, Wortsman X, Grotts J, Matucci-Cerrinic M, Ranganath VK, Furst DE. PMID: 29525847.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    17. Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials. Arthritis Care Res (Hoboken). 2018 03; 70(3):439-444. Namas R, Tashkin DP, Furst DE, Wilhalme H, Tseng CH, Roth MD, Kafaja S, Volkmann E, Clements PJ, Khanna D, Participants in the Scleroderma Lung Study I and members of the Scleroderma Lung Study II Research G. PMID: 28544580; PMCID: PMC5700860.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    18. Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. N Engl J Med. 2018 01 04; 378(1):35-47. Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE, SCOT Study Investigators. PMID: 29298160; PMCID: PMC5846574.
      View in: PubMed   Mentions: 187     Fields:    Translation:HumansCTClinical Trials
    19. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One. 2018; 13(1):e0189498. Gorlova OY, Li Y, Gorlov I, Ying J, Chen WV, Assassi S, Reveille JD, Arnett FC, Zhou X, Bossini-Castillo L, Lopez-Isac E, Acosta-Herrera M, Gregersen PK, Lee AT, Steen VD, Fessler BJ, Khanna D, Schiopu E, Silver RM, Molitor JA, Furst DE, Kafaja S, Simms RW, Lafyatis RA, Carreira P, Simeon CP, Castellvi I, Beltran E, Ortego N, Amos CI, Martin J, Mayes MD. PMID: 29293537; PMCID: PMC5749683.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    20. Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). Am J Respir Crit Care Med. 2018 03 01; 197(5):644-652. Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin DP, Khanna D. PMID: 29099620; PMCID: PMC6008871.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    21. Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition. J Scleroderma Relat Disord. 2017 May; 2(2):115-120. Suliman YA, Bruni C, Johnson SR, Praino E, Alemam M, Borazan N, Cometi L, Meyers B, Khanna D, Allanore Y, Baron M, Krieg T, Herrick A, Afonso A, Distler O, Kafaja S, Denton CP, Matucci-Cerinic M, Furst DE. PMID: 30569018; PMCID: PMC6296474.
      View in: PubMed   Mentions: 20  
    22. Structural Validity of the Rheumatology Attitudes Index in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study. J Rheumatol. 2017 06; 44(6):795-798. Gholizadeh S, Mills SD, Fox RS, Merz EL, Roesch SC, Clements PJ, Kafaja S, Furst DE, Khanna D, Malcarne VL. PMID: 28412704; PMCID: PMC5457305.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. Chest. 2017 Apr; 151(4):813-820. Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM. PMID: 28012804; PMCID: PMC5472514.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    24. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719. Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM, Sclerodema Lung Study II Investigators. PMID: 27469583; PMCID: PMC5014629.
      View in: PubMed   Mentions: 355     Fields:    Translation:Humans
    25. Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience. Ann Am Thorac Soc. 2016 06; 13(6):793-802. Miele CH, Schwab K, Saggar R, Duffy E, Elashoff D, Tseng CH, Weigt S, Charan D, Abtin F, Johannes J, Derhovanessian A, Conklin J, Ghassemi K, Khanna D, Siddiqui O, Ardehali A, Hunter C, Kwon M, Biniwale R, Lo M, Volkmann E, Torres Barba D, Belperio JA, Sayah D, Mahrer T, Furst DE, Kafaja S, Clements P, Shino M, Gregson A, Kubak B, Lynch JP, Ross D, Saggar R. PMID: 27078625; PMCID: PMC5461989.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    26. Management of Widespread Skin Thickening in Diffuse Systemic Sclerosis. Curr Treatm Opt Rheumatol. 2016 Mar; 2(1):49-60. Kafaja S, Clements P. PMID: 27330933; PMCID: PMC4907542.
      View in: PubMed   Mentions: 1  
    27. Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study. J Rheumatol. 2015 Sep; 42(9):1624-30. Mills SD, Fox RS, Merz EL, Clements PJ, Kafaja S, Malcarne VL, Furst DE, Khanna D. PMID: 26034157; PMCID: PMC4809411.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    28. Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2015 Aug; 54(8):1369-79. Wallace B, Kafaja S, Furst DE, Berrocal VJ, Merkel PA, Seibold JR, Mayes MD, Khanna D. PMID: 25667436; PMCID: PMC4502336.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    29. Rheumatoid arthritis: are current research-based guidelines clinically relevant? J Rheumatol. 2014 Aug; 41(8):1569-70. Kafaja S, Furst DE. PMID: 25086136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. American College of Rheumatology report on reasonable use of musculoskeletal ultrasonography in rheumatology clinical practice. Arthritis Care Res (Hoboken). 2012 Nov; 64(11):1625-40. McAlindon T, Kissin E, Nazarian L, Ranganath V, Prakash S, Taylor M, Bannuru RR, Srinivasan S, Gogia M, McMahon MA, Grossman J, Kafaja S, FitzGerald J. PMID: 23111854.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    31. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 Jun; 64(6):797-808. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM, American College of Rheumatology. PMID: 22556106; PMCID: PMC3437757.
      View in: PubMed   Mentions: 426     Fields:    Translation:HumansPHPublic Health